Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.

Baandrup, Lone; Ebdrup, Bjørn H; Rasmussen, Jesper Ø; Lindschou, Jane; Gluud, Christian; Glenthøj, Birte Y

Baandrup, Lone; Ebdrup, Bjørn H; Rasmussen, Jesper Ø; Lindschou, Jane; Gluud, Christian; Glenthøj, Birte Y.

Affiliation

Baandrup L; Centre for Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, Mental Health Services of the Capital Region, Nordre Ringvej 29-67, Glostrup, Denmark, 2600.

Cochrane Database Syst Rev ; 3: CD011481, 2018 Mar 15.

Article in En | MEDLINE | ID: mdl-29543325

Subject(s)

Benzodiazepines/adverse effects; Substance Withdrawal Syndrome/drug therapy; Withholding Treatment; Adult; Antidepressive Agents/therapeutic use; Aspartic Acid/therapeutic use; Benzodiazepines/administration & dosage; Buspirone/therapeutic use; Carbamazepine/therapeutic use; Ethylamines/therapeutic use; Flumazenil/therapeutic use; Homeopathy; Humans; Imidazoles/therapeutic use; Lithium Compounds/therapeutic use; Melatonin/therapeutic use; Paroxetine/therapeutic use; Pregabalin/therapeutic use; Progesterone/therapeutic use; Pyridines/therapeutic use; Randomized Controlled Trials as Topic; Sulfides/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Complementary Medicines: Homeopatia Main subject: Substance Withdrawal Syndrome / Benzodiazepines / Withholding Treatment Type of study: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Cochrane Database Syst Rev Year: 2018 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google